Literature DB >> 19759193

Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.

Yu-Chi Chen1, Donna M Sosnoski, Ujjawal H Gandhi, Leah J Novinger, K Sandeep Prabhu, Andrea M Mastro.   

Abstract

Breast cancer frequently metastasizes to the skeleton resulting in bone degradation due to osteoclast activation. Metastases also downregulate differentiation and the bone-rebuilding function of osteoblasts. Moreover, cancer cells trigger osteoblast inflammatory stress responses. Pro-inflammatory mediators such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), expressed by osteoblasts (MC3T3-E1) stimulated with human breast cancer cell (MDA-MB-231) conditioned medium, are pivotal to osteoclast activation and metastasis. Given that these genes are regulated by nuclear factor-kappaB (NF-kappaB), a redox-sensitive transcription factor, we hypothesized that selenium (Se) could abrogate the inflammatory response to metastatic breast cancer cells by modulating NF-kappaB. Caffeic acid phenethyl ester and parthenolide inhibited NF-kappaB activation, as seen by gel shift assays and immunoblotting for p65 in nuclear fractions, as well as decreased production of IL-6 and MCP-1. Supplementation of MC3T3-E1 with methylseleninic acid (MSA) (0.5 microM to 4 microM) reduced the activation of NF-kappaB leading to a decrease in IL-6, MCP-1, COX-2 and iNOS in response to MDA-MB-231 conditioned medium. Addition of MSA to osteoblasts for as little as 15 min suppressed activation of NF-kappaB suggesting that short-lived active metabolites might be involved. However, brief exposure to MSA also brought about an increase in selenoprotein glutathione peroxidase 1. In summary, our data indicate that the osteoblast response to metastatic breast cancer cells is regulated by NF-kappaB activation, which can be effectively suppressed by MSA either through short-lived active metabolites and/or selenoproteins. Thus, Se supplementation may prevent the osteoblast inflammatory response or dampen the vicious cycle established when breast cancer cells, osteoblasts and osteoclasts interact.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759193      PMCID: PMC2791325          DOI: 10.1093/carcin/bgp227

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  50 in total

1.  Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.

Authors:  Robyn R Mercer; Chiaki Miyasaka; Andrea M Mastro
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer.

Authors:  Julian A Schardt; Manfred Meyer; Claudia H Hartmann; Falk Schubert; Oleg Schmidt-Kittler; Christine Fuhrmann; Bernhard Polzer; Marco Petronio; Roland Eils; Christoph A Klein
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

3.  The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages.

Authors:  Hema Vunta; Faith Davis; Umamaheswari D Palempalli; Deepa Bhat; Ryan J Arner; Jerry T Thompson; Devin G Peterson; C Channa Reddy; K Sandeep Prabhu
Journal:  J Biol Chem       Date:  2007-04-17       Impact factor: 5.157

4.  Metabolic transformation of methylseleninic acid through key selenium intermediate selenide.

Authors:  Kazuo T Suzuki; Kazuki Kurasaki; Sayaka Ogawa; Noriyuki Suzuki
Journal:  Toxicol Appl Pharmacol       Date:  2006-04-05       Impact factor: 4.219

5.  Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.

Authors:  Guang-Xun Li; Hongbo Hu; Cheng Jiang; Todd Schuster; Junxuan Lü
Journal:  Int J Cancer       Date:  2007-05-01       Impact factor: 7.396

6.  Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.

Authors:  Jong-Min Park; Aeyung Kim; Jang-Hee Oh; An-Sik Chung
Journal:  Carcinogenesis       Date:  2006-10-27       Impact factor: 4.944

Review 7.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

8.  Kinetics of metastatic breast cancer cell trafficking in bone.

Authors:  Pushkar A Phadke; Robyn R Mercer; John F Harms; Yujiang Jia; Andra R Frost; Jennifer L Jewell; Karen M Bussard; Shakira Nelson; Cynthia Moore; John C Kappes; Carol V Gay; Andrea M Mastro; Danny R Welch
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

9.  Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase. Isolation and enzymatic characterization of human selenoprotein p.

Authors:  Y Saito; T Hayashi; A Tanaka; Y Watanabe; M Suzuki; E Saito; K Takahashi
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

10.  Apoptotic cellular events for selenium compounds involved in cancer prevention.

Authors:  Hidemi Rikiishi
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

View more
  21 in total

1.  Breast cancer at bone metastatic sites: recent discoveries and treatment targets.

Authors:  Osama Hussein; Svetlana V Komarova
Journal:  J Cell Commun Signal       Date:  2011-01-19       Impact factor: 5.782

Review 2.  Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.

Authors:  John T Pinto; Jeong-In Lee; Raghu Sinha; Melanie E MacEwan; Arthur J L Cooper
Journal:  Amino Acids       Date:  2010-04-10       Impact factor: 3.520

Review 3.  Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 4.  Animal products, diseases and drugs: a plea for better integration between agricultural sciences, human nutrition and human pharmacology.

Authors:  Olav A Christophersen; Anna Haug
Journal:  Lipids Health Dis       Date:  2011-01-20       Impact factor: 3.876

5.  Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell lines.

Authors:  Fabiola Rusolo; Francesca Capone; Raffaella Pasquale; Antonella Angiolillo; Giovanni Colonna; Giuseppe Castello; Maria Costantini; Susan Costantini
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

6.  Correlation between bone mineral density and serum trace element contents of elderly males in Beijing urban area.

Authors:  Liang Wang; Haotian Yu; Guohua Yang; Yan Zhang; Wenjiao Wang; Tianjiao Su; Weifeng Ma; Fan Yang; Liying Chen; Li He; Yuanzheng Ma; Yan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 7.  The Regulation of Pathways of Inflammation and Resolution in Immune Cells and Cancer Stem Cells by Selenium.

Authors:  Bastihalli T Diwakar; Arvind M Korwar; Robert F Paulson; K Sandeep Prabhu
Journal:  Adv Cancer Res       Date:  2017-08-31       Impact factor: 6.242

8.  Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.

Authors:  Ken Tawara; Julia T Oxford; Cheryl L Jorcyk
Journal:  Cancer Manag Res       Date:  2011-05-18       Impact factor: 3.989

9.  Distribution of selenium and oxidative stress in breast tumor-bearing mice.

Authors:  Chih-Hung Guo; Simon Hsia; Pei-Chung Chen
Journal:  Nutrients       Date:  2013-02-20       Impact factor: 5.717

Review 10.  Selenium in bone health: roles in antioxidant protection and cell proliferation.

Authors:  Huawei Zeng; Jay J Cao; Gerald F Combs
Journal:  Nutrients       Date:  2013-01-10       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.